Trial Profile
Single-blind, Randomized, Multicenter Comparison of FSME IMMUN NEW and ENCEPUR: Safety and Tolerability of Two Vaccinations in Healthy Volunteers Aged 16 to 65 Years.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Adverse reactions
- Sponsors Pfizer
- 05 Jun 2015 New trial record